Literature DB >> 26862938

Increased Ghrelin Levels and Unchanged Adipocytokine Levels in Major Depressive Disorder.

Özgür Korhan Tunçel1, Seher Akbaş2, Birşen Bilgici1.   

Abstract

OBJECTIVE: One of the hypotheses of the pathophysiology of major depressive disorder (MDD) proposes that there is a relationship between adipocytokine and ghrelin levels and depression.
METHODS: Patients with major depression with a BMI ≤25 kg/m2 between the ages of 11 and 18 years (n = 30) were compared with a healthy control group (n = 30). Both groups were evaluated across a pretreatment period (MD-PT) and an improved period (MD-I). We measured serum leptin, adiponectin, resistin, and ghrelin levels and other parameters related to metabolic syndrome, such as glucose, insulin, insulin resistance (homeostasis model assessment [HOMA]), triglycerides (TG), and total cholesterol (TCHOL).
RESULTS: Leptin, adiponectin, and resistin levels did not differ across groups; however, ghrelin levels were increased in the MD-I group compared with the control and MD-PT groups (p < 0.05). HOMA levels were also higher in the MD-PT group than in the control group (p < 0.05). After treatment, there was no difference in this measurement.
CONCLUSIONS: The relationship between adipocytokines and major depression may be dependent on ghrelin levels as a result of antidepressant treatment and subsequent obesity.

Entities:  

Keywords:  adipocytokine; depression; ghrelin; insulin resistance; sertraline

Mesh:

Substances:

Year:  2016        PMID: 26862938     DOI: 10.1089/cap.2015.0149

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  6 in total

1.  Association Between Self-rating Depression Scores and Total Ghrelin and Adipokine Serum Levels in a Large Population-Based Sample.

Authors:  Dirk Alexander Wittekind; Jürgen Kratzsch; Ronald Biemann; Roland Mergl; Steffi Riedel-Heller; Veronika Witte; Arno Villringer; Michael Kluge
Journal:  Front Psychiatry       Date:  2022-05-11       Impact factor: 5.435

Review 2.  Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder.

Authors:  Rachael Horne; Jane A Foster
Journal:  Front Psychiatry       Date:  2018-10-22       Impact factor: 4.157

Review 3.  Increasing Adiponergic System Activity as a Potential Treatment for Depressive Disorders.

Authors:  Douglas Affonso Formolo; Thomas Ho-Yin Lee; Suk-Yu Yau
Journal:  Mol Neurobiol       Date:  2019-05-28       Impact factor: 5.590

Review 4.  Depression and Cardiovascular Disease: The Viewpoint of Platelets.

Authors:  Patrizia Amadio; Marta Zarà; Leonardo Sandrini; Alessandro Ieraci; Silvia Stella Barbieri
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

5.  Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study.

Authors:  Smaranika Rahman; Amena Alam Shanta; Sohel Daria; Zabun Nahar; Mohammad Shahriar; Mma Shalahuddin Qusar; Sardar Mohammad Ashraful Islam; Mohiuddin Ahmed Bhuiyan; Md Rabiul Islam
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

6.  Preliminary evidence of acylated ghrelin association with depression severity in postmenopausal women.

Authors:  Maria Fernanda Naufel; Amanda Paula Pedroso; Lila Missae Oyama; Mônica Marques Telles; Helena Hachul; Eliane Beraldi Ribeiro
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.